| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Guidelines |
| Article Title |
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian Li, Ming Wang, Bo Zhang, Xin Wu, Tian-Long Lin, Xiu-Feng Liu, Ye Zhou, Xin-Hua Zhang, Hao Xu, Li-Jing Shen, Jing Zou, Ping Lu, Dong Zhang, Wei-Jun Gu, Mei-Xia Zhang, Jian Pan and Hui Cao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hui Cao, MD, Chief Doctor, Librarian, Surgical Oncologist, Department of General Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 160 Pujian Road, Pudong New District, Shanghai 200217, China. caohuishcn@hotmail.com |
| Key Words |
Side effects; Gastrointestinal stromal tumor; Tyrosine kinase inhibitors; Consensus guideline; China |
| Core Tip |
This is the first consensus focusing on tyrosine kinase inhibitor (TKI)-associated side effects in gastrointestinal stromal tumors (GISTs). The authors include not only oncologist, oncology surgeon, but also doctors from other relative specialties, such as cardiology, dermatology, nephrology, and endocrinology. The content consists of clinical symptoms, mechanisms, and management. Because except for GISTs, TKIs in this consensus are also used in other tumors, this consensus will be helpful to many oncologists in different specialties. |
| Publish Date |
2018-12-13 06:32 |
| Citation |
Li J, Wang M, Zhang B, Wu X, Lin TL, Liu XF, Zhou Y, Zhang XH, Xu H, Shen LJ, Zou J, Lu P, Zhang D, Gu WJ, Zhang MX, Pan J, Cao H; Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors. World J Gastroenterol 2018; 24(46): 5189-5202 |
| URL |
https://www.wjgnet.com/1007-9327/full/v24/i46/5189.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v24.i46.5189 |
